1. Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A)
   Mingqiu Chen et al, 2020, BMC Cancer CrossRef
2. Modulators of Redox Metabolism in Head and Neck Cancer
   Xiaofei Chen et al, 2018, Antioxidants & Redox Signaling CrossRef
3. Nimotuzumab
   , 2016, Reactions Weekly CrossRef
4. Efficacy and Safety of Concurrent Chemoradiotherapy Combined with Nimotuzumab in Elderly Patients with Esophageal Squamous Cell Carcinoma: A Prospective Real-world Pragmatic Study
   Nuo Yu et al, 2023, Current Cancer Drug Targets CrossRef
5. A phase I study evaluating combined nimotuzumab and neoadjuvant chemoradiotherapy followed by surgery in locally advanced esophageal cancer
   Saichun Qi et al, 2019, Cancer Chemotherapy and Pharmacology CrossRef
6. Comparison of involved-field intensity-modulated radiotherapy combined with S-1 vs radiotherapy alone for elderly patients with esophageal cancer
   Li-Hua Liu et al, 2022, World Journal of Clinical Cases CrossRef
7. Cetuximab or nimotuzumab plus intensity-modulated radiotherapy versus cisplatin plus intensity-modulated radiotherapy for stage II-IVb nasopharyngeal carcinoma
   Rui You et al, 2017, International Journal of Cancer CrossRef